Metrizamide—CSF Contrast Medium

Joseph F. Sackett, Charles M. Strother, Charles E. Quaglieri, Manucher J. Javid, Allan B. Levin, Thomas A. Duff

Radiology · 1977 · 43 citations · 6 references

Concepts

Abstract

Two-hundred-fifteen patients were evaluated with metrizamide, a new water-soluble contrast agent for use in the subarachnoid spaces. Side effects were reported in 67% of these; 39% were moderate or severe. Cervical injections monitored by fluoroscopy provide the most precise positioning of the medium. The benefits of metrizamide use outweigh its risk.

References

6